EUCTR2009-011175-70-GB
Active, not recruiting
Not Applicable
A randomised factorial trial of N-acetylcysteine prophylaxis and iso-osmolar versus low-osmolar contrast media on kidney function in patients at risk of contrast induced nephropathy following cardiac catheterisation for percutaneous coronary interventions - the CON NEC T” trial - CONNECT
iverpool Heart and Chest Hospital0 sitesApril 16, 2009
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- iverpool Heart and Chest Hospital
- Status
- Active, not recruiting
- Last Updated
- 13 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •eGFR \< 60 ml/m (as calculated by modified MDRD equation with local laboratory correction factor)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •1\. Patients who had coronary angiography or other procedure with contrast exposure (CTPA etc.) within 2 weeks of PCI
- •2\. Unable to consent
- •3\. Patients undergoing angiographic investigations as a prelude to planned cardiac surgery
- •4\. Cardiogenic shock
- •5\. Unlikely to attend for follow up blood tests
- •6\. Presence of non cardiac illness that might affect life expectancy
- •7\. Any previous allergic reaction to contrast media or NAC
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A randomised trial comparing two strategies for preventing kidney failure after angioplastyKidney function impairment/coronary artery disease/contrast-induced nephropathyUrological and Genital DiseasesDrug- and heavy-metal-induced tubulo-interstitial and tubular conditionsISRCTN15027862iverpool Heart and Chest Hospital NHS Trust (UK)200
Completed
Not Applicable
A randomised controlled study of N-Acetylcysteine in liver transplantatioSurgery: Liver transplantSurgeryLiver transplantISRCTN46492332Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)170
Completed
Not Applicable
Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease.Chronic obstructive pulmonary diseaseRespiratoryPulmonary diseaseISRCTN21676344Health Research Council of New Zealand50
Recruiting
Phase 2
The Post Anaesthesia N-Acetycysteine Cognitive Evaluation trial, investigating the potential for N-Acetylcysteine to reduce cognitive dysfunction following major elective non-cardiac surgeryPost Operative Cognitive DysfunctionSurgical Stress ResponsePost Operative Mood DisorderPost surgical painAnaesthesiology - AnaestheticsMental Health - Studies of normal psychology, cognitive function and behaviourSurgery - Other surgeryACTRN12614000411640The Geelong Hospital370
Recruiting
Phase 2
Treatment using N-acetyl cysteine (Injection) to reduce occurrence of muscle weakness and death in patients admitted with organophosphate (OP) pesticide poisoning.Health Condition 1: T600- Toxic effect of organophosphate and carbamate insecticidesCTRI/2020/09/028060Christian medical college Vellore